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Mammalian cardiac Purkinje fibers (PFs) are specified from ventricular trabecular
myocardium during mid-gestation and undergo limited proliferation before assuming
their final form. MicroRNA-1 (miR-1), a negative regulator of proliferation, is normally
expressed in the heart at low levels during the period of PF specification and outgrowth,
but expression rises steeply after birth, when myocardial proliferation slows and
postnatal cardiac maturation and growth commence. Here, we test whether premature
up-regulation and overexpression of miR-1 during the period of PF morphogenesis
influences PF development and function. Using a mouse model in which miR-1 is
expressed under the control of the Myh6 promoter, we demonstrate that premature miR-
1 expression leads to PF hypoplasia that persists into adulthood, and miR-1 TG mice
exhibit delayed conduction through the ventricular myocardium beginning at neonatal
stages. In addition, miR-1 transgenic embryos showed reduced proliferation within the
trabecular myocardium and embryonic ventricular conduction system (VCS), a source
of progenitor cells for the PF. This repression of proliferation may be mediated by direct
translational inhibition by miR-1 of the cyclin dependent kinase Cdk6, a key regulator of
embryonic myocardial proliferation. Our results suggest that altering the timing of miR-
1 expression can regulate PF development, findings which have implications for our
understanding of conduction system development and disease in humans.
Keywords: cardiac conduction system, cardiac development, microRNA, miR-1, Purkinje fibers, cardiac
maturation, heart block
INTRODUCTION
The cardiac ventricular conduction system (VCS) is a multicomponent functional unit composed
of specialized cardiomyocytes that transmit electrical impulses from the atrial to the ventricular
myocardium. The proximal portion of VCS, the atrioventricular bundle, originates in the
compact AV node, traverses the central fibrous body, and then bifurcates into the right and left
bundle branches. Within each ventricle, the bundle branches ramify into conduction fascicles,
Abbreviations: PF, Purkinje fiber; miR-1, microRNA-1; VCS, ventricular conduction system.
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which, in turn, arborize into a finely branched network of
specialized cardiomyocytes known as Purkinje fibers (PF). At
their distal ends, PFs directly activate working cardiomyocytes,
leading to mechanically synchronous ventricular contraction.
Malfunction and/or malformation of the Purkinje network
can lead to conduction delay, dyssynchronous contraction,
and tachyarrhythmias, and are important sources of
morbidity in patients with congenital and acquired heart
disease (Boyden et al., 2016).
PF myocytes are specified from a pool of bipotent ventricular
cardiomyocyte precursors shortly after ventricular trabeculation
and develop through a combination of slow proliferation and
continued recruitment until late embryogenesis (Gourdie et al.,
1995; Miquerol et al., 2010). The process of PF outgrowth
continues into the perinatal period, after which the PF matures
into its final physiological phenotype. While the regulatory
determinants of this developmental program have not been fully
established, a key factor in determining the functional properties
of the whole unit is maintenance of the proper ratio of conduction
system cells to working myocardium: PF hypoplasia leads to
conduction defects (Jay et al., 2004; Kim et al., 2016) while PF
excess causes reduced contractile force and arrhythmias (Park
et al., 2013). In the murine heart, PFs comprise only about 1%
of ventricular myocytes, partly because the rates of proliferation
of PF cells and their trabecular myocardial precursors are
substantially lower than that of working myocytes in the compact
myocardial layer (Miquerol et al., 2010).
Among the key regulators of ventricular myocardial
proliferation in the late developmental and perinatal period is the
muscle-specific microRNA, miR-1. During mammalian cardiac
development, miR-1 expression is detectable in cardiomyocytes
shortly after cardiogenesis and is steeply upregulated in the
postnatal period, when miR-1 expression comprises a large
percentage of the total microRNA in the heart. MiR-1 is
expressed throughout atrial and ventricular myocardium,
and within the specialized conduction tissue, but not in non-
myocyte cells within the heart (Rao et al., 2009; Cao et al.,
2012). Overexpression of miR-1 under the control of the Myh7
promoter results in early embryonic lethality, partly due to
decreased ventricular cardiomyocyte proliferation. Conversely,
homozygous deletion of one miR-1 allele (miR-1-2) leads to
increased proliferation in postnatal hearts as compared to
WT hearts, suggesting that miR-1 is involved in negatively
regulating proliferation during perinatal cardiac maturation
(Zhao et al., 2005, 2007).
In addition to the effects on proliferation, gain of function
models have demonstrated that excess miR-1 can lead to
arrhythmias including atrioventricular block and ventricular
tachycardia in adult animals. These arrhythmias have been
attributed to the capacity of miR-1 to inhibit expression of
various gap junctions, ion channels, calcium handling proteins,
and other electrophysiologically salient targets (Yang et al., 2007;
Terentyev et al., 2009; Zhang et al., 2013; Su et al., 2017). In
addition, previous work has demonstrated that chronic exposure
to elevated miR-1 levels leads to abnormal cardiac growth and
contractile dysfunction, with inhibition of sarcomere assembly
(Ai et al., 2012).
Here, we extend these studies by focusing on PF development
and maturation using a transgenic mouse in which the Myh6
promoter drives miR-1 overexpression in the heart. Several
studies have demonstrated that Myh6 promoter activity is present
during embryogenesis beginning around embryonic day (E) 10,
albeit at lower levels than in the adult heart (Lyons et al., 1990;
Subramaniam et al., 1991; Toib et al., 2012). Consistent with
these previous results, we detected up-regulation of miR-1 in
our Myh6-miR-1 transgenic embryos during the critical period
of VCS specification and outgrowth (between E10.5 and E14.5).
We further show that Myh6-miR-1 animals have a hypoplastic
VCS, reduced proliferation of PF precursors, and early-onset
electrocardiographic abnormalities including broadened QRS
complex (reflecting slowed transit through the VCS). Finally,
we defined the cyclin-dependent kinase Cdk6 as a target of
miR-1 in the mouse heart and a possible contributor to the
observed hypoplasia. Our results demonstrate the importance of
the timing of miR-1 expression relative to cardiac development
and conduction system morphogenesis.
MATERIALS AND METHODS
Use of Genetically Modified Mice
UCSF is accredited by Association for Assessment and
Accreditation of Laboratory Animal Care International
(AAALAC), effective June 14, 2004, and experimentation
was carried out in strict accordance with AAALAC guidelines.
All animal experiments were reviewed and approved by the
Institutional Animal Care and Use Committee (IACUC) at UCSF.
Generation of Myh6-miR-1 TG (hereafter: miR-1 TG) has
been reported previously (Zhao et al., 2005). CCS-LacZ mice were
originally generated by Glenn Fishman’s lab (Rentschler et al.,
2001) and were provided to us by Benoit Bruneau. Irx3-LacZ
mice were generated by Chi-Chung Hui’s lab and provided by
Benoit Bruneau (Zhang et al., 2011).
Histology
Embryonic, neonatal and adult miR1-TG and WT littermates
were sacrificed and hearts were removed and processed for
hematoxylin-eosin staining using standard techniques. For
whole-mount Bluo-Gal staining, adult hearts were bisected,
fixed overnight in formalin, and incubated with a solution
containing 1 mg/mL halogenated indolyl-β-galactoside (Bluo-
Gal, Invitrogen, Catalog No. 15519028) for 24 h at room
temperature, followed with washing and fixation. To facilitate
comparison between genotypes, WT and TG littermate hearts
were processed and stained in parallel using the same staining
solution for identical durations. Hearts were photographed
under identical lighting conditions after clearing in 2:1 benzyl
alcohol-benzyl benzoate (Sigma-Aldrich, Catalog No. 305197 and
B6630, respectively).
Morphometric Quantification of His
Purkinje System
For quantification of whole-mount Irx3-LacZ staining, we
used 5 P5 miR-1 TG hearts and 3 WT littermates that were
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each heterozygous for Irx3-LacZ. All hearts were fixed and
stained with Bluo-Gal in parallel, then cleared for whole-
mount photography under identical lighting conditions. Images
of PFs were desaturated and color inverted to make bluo-gal
positive areas have higher pixel intensity. Pixel intensity was
then integrated across each image, averaged, and normalized to
the average WT value to arrive at relative PF density. These
values were averaged and an unpaired t-test was used to test for
difference from the WT with p< 0.05 deemed significant.
Whole-Mount in situ Hybridization
RNA probe for Bmp10 was generated by in vitro transcription
in the antisense direction using Ambion Message Machine kit
(AM1340), followed by labeling with the DIG RNA labeling kit
(Roche, Catalog No. 11277073910). 3 miR-1 TG and 3 WT E10.5
embryos were dissected and processed for in situ hybridization as
previously described (Vedantham et al., 2013).
Immunohistochemistry
For immunohistochemistry and acetylcholinesterase staining,
hearts were fixed overnight in formalin, washed in PBS, and
moved through a sucrose gradient into 30% sucrose overnight.
They were then embedded in Optimal Cutting Temperature
Compound (Fisher Scientific, Catalog No. 23-730-571) prior to
cryosectioning. Sections were washed in PBS, blocked in 5% goat
serum for 1 h, incubated with primary antibody (Phosphohistone
H3 – 1:500, Millipore Sigma 06-570, Hcn4 – 1:200, Alomone
Labs #APC-052; Connexin-40 – 1:200, Alpha Diagnostics Cx40-
A; Connexin-43 – 1:100, Sigma SAB 4501173; NaV1.5 – 1: 200,
Alomone Labs #ASC-005; Beta-Galactosidase – 1:200, Abcam
Ab9361), washed, and incubated for 1 h with a secondary
antibody (Alexa Fluor, Life Technologies) before a final wash
and mounting in Vectashield with DAPI (Vector Laboratories,
Catalog No. H-1200). To assess mitotic index, the number
of phosphohistone H3-positive cells within the trabecular
myocardium and compact myocardium of each section was
determined, and then divided by the total number of nuclei.
For determination of mitotic index specifically in VCS, beta-
galactosidase+ myocardium in sections from Irx3-LacZ;miR-
1 TG and Irx3-LacZ littermates was manually segmented
using ImageJ, and phosphohistone H3-positive cells within this
compartment were counted and divided by the total number
of nuclei in the beta-galactosidase positive cells. A total of
3 hearts for each genotype was used with at least 2 distinct
sections examined per heart. Statistical comparison between WT
and TG was performed with unpaired t-tests with p < 0.05
deemed significant.
Quantification of Cardiomyocyte Size
and Number
To measure cardiomyocyte cross sectional area,
photomicrographs taken from wheat-germ-agglutinin stained
sections (4 sections per heart from 3 WT and 3 miR-1 TG
hearts) were loaded onto ImageJ and 10 cardiomyocytes
sectioned en face were selected at random from each section
(total of 120 per genotype) and manually segmented for area
measurements. Cross sectional areas between the two genotypes
were compared using two-tailed t-tests. To estimate cellularity,
a tangent line to the epicardium was drawn and then a second
line perpendicular to the tangent was drawn between the
endocardium and epicardium. Cell diameters were counted
along that line. This process was repeated in the same sections
from 3 positions in the LV and at 3 sites in the RV, each
with a distinct tangent line along the epicardium. Statistical
comparisons were made with unpaired t-tests and p < 0.05 was
deemed statistically significant.
Optical Projection Tomography
After whole-mount Bluo-Gal staining, neonatal hearts were
embedded in low-melt agarose, cleared with 2:1 benzyl
alcohol:benzyl benzoate, and imaged with a Bioptonics
optical projection tomography scanner model 3001M (MRC
Technology, Edinburgh, UK). Image processing and 3D
reconstruction was performed with NR Recon (Bioptonics) and
videos were generated with Amira (Visage Imaging).
Quantitative Analysis of Gene Expression
The ventricles of hearts from neonatal and adult mice were
dissected in nuclease-free PBS and homogenized in Tri-Reagent
with a bead homogenizer system (Bullet Blender, Next Advance,
model BBX24). Total RNA was prepared from the aqueous
fraction with isopropanol-ethanol precipitations. MicroRNA
quantitative PCR and messenger RNA quantitative PCR were
performed on an Applied Biosystems 7900HT machine with
Taqman reagents (Life Technologies). PCR primers used are
given in Supplementary Table S1.
For quantification of connexin-40 plaque intensity, individual
connexin-40 plaques were manually segmented and fluorescence
intensity was measured with image J with subtraction of
background fluorescence from a manually selected connexin-40
negative adjacent region. At least 5 sections were examined per
heart for 3 hearts of each genotype and statistical comparisons
were performed with a Mann–Whitney test with p < 0.05
deemed significant.
Western Blot
Adult WT and miR-1 TG mouse hearts were snap-frozen and
ground to a fine powder using a mortar and pestle in the
presence of liquid nitrogen. Powdered hearts were lysed in
RIPA buffer using a homogenizer, and Bradford assays were
performed on the cleared lysates. Fifty micrograms of total
protein was run on a 10% tris-glycine gel, and transferred
in 20% methanol onto a PVDF membrane (100V for 1.5 h
at 4◦C). The blot was blocked in 5% milk in TBST (0.05%
tween-20) before incubation with anti-Cdk6 antibody (sc-7181,
1:1000 dilution) for 16 h at 4◦C. HRP-conjugated secondary
antibody (1:5000 for 1 h) was then applied and the blot
was developed using Pierce ECL substrate (Thermo Fisher
Scientific, Catalog No. 32106). For endogenous control, blots
were rinsed, blocked, and re-probed with GAPDH antibody
(SC-2313, 1:2500 dilution) following the same protocol as
for Cdk6 detection.
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Cell Culture and Transfections
For knockdown studies, HL-1 cells were maintained in
Claycomb media supplemented with 10% fetal bovine serum,
100 units/mL streptomycin/penicillin, 2 mM gutamine, and
0.1 mM norepinephrine. Confluent HL-1 cells were transfected
with miR-1 inhibitor (Dharmacon, Catalog No. IH-310376-08-
0002) by Amaxa nucleofection and harvested 48 h later for gene
expression analysis as described above. All assays were performed
in triplicate and data is expressed as mean ± standard deviation.
Unpaired t-test was used to calculate statistical significance with
p< 0.05 deemed significant.
Adult and Neonatal ECG Recording
For adults, mice were administered 2% isoflurane and placed
on a warmed platform with continuous temperature monitoring.
Subcutaneous needle electrodes (AD Instruments, MLA1203A)
were placed in limb lead configurations and signals were acquired
using the PowerLab 4/30 analog-to-digital converter (ML866P)
and a Dual Bioamp signal conditioner (AD Instruments,
ML135), with offline data analysis using ChartPro software (AD
Instruments, ML866P). Neonatal ECGs were performed as above
without isoflurane and continuous temperature monitoring.
Following Boukens et al. (2013), QRS intervals were measured
in limb lead aVF configuration in which the measured QRS
end is contemporaneous with the end of ventricular activation.
Data are displayed as mean ± standard deviation, and statistical
comparison was performed using unpaired t-tests with p less than
0.05 deemed significant.
Mouse Transmitter Implantation and
Recording of Awake ECGs
For transmitter implantation, adult miR-1 TG and WT mice
were first anesthetized with 2% isoflurane, after which the
thorax was epilated and sterilized with betadine. A 2 cm skin
incision was made lateral to the spine and a subcutaneous pocket
was created to hold the transmitter (ETA-F10, Data Sciences
International, St. Paul, MN, United States). Sterilized recording
leads (Data Sciences International) were tunneled to the left
lower thorax and to the anterior right shoulder through small
incisions and were sutured to intercostal and pectoralis muscles,
respectively. The generator was anchored to the dorsal thoracic
musculature using a suture, and the leads and generator were
placed in the subcutaneous pocket, after which the incision was
closed. Animals were allowed to recover for 8 days prior to
initiating recording. Recovered miR-1 TG and WT adult mice
with transmitters were housed in individual shielded cages and
continuous ECG tracings were recorded for 24 h using the DSI
telemetry system. ECGs were analyzed for heart rate, intervals,
and the presence of arrhythmias offline using DSI software. Data
for intervals are displayed as mean ± standard deviation, and
statistical comparison was performed using unpaired t-tests with
p less than 0.05 deemed significant.
Mouse Echocardiography
Cardiac dimensions and function were assessed by measuring
left ventricular dimensions with M-Mode in gently restrained
unanesthetized 8 week old mice using a Vevo770 ultrasound
machine (Visual Sonics). Statistical comparison was performed
using unpaired t-tests with p less than 0.05 deemed significant.
Measurement of Heart Weight to Body
Weight Ratio
Mice at neonatal stage P0 (n = 5 for WT and TG), 2 weeks (n = 3
for WT; n = 6 for TG), 6 weeks (n = 5 for WT and TG), and
17 weeks of age (n = 4 for WT and TG) were weighed prior to
euthanasia and removal of hearts. Residual blood was removed
from hearts with gentle pressure and hearts were dissected free of
extra-cardiac tissue. Hearts were washed in PBS, patted dry, and
weighed. Statistical comparisons were made with unpaired t-tests
and p< 0.05 was deemed statistically significant.
RESULTS
Timing of MiR-1 Overexpression in MiR-1
TG Hearts
Myh6-miR-1 transgenic mice (hereafter, miR-1 TG) were
generated for an earlier study using pronuclear injection of a
construct bearing the Myh6 promoter upstream of pre-miR-1
and were previously reported (Figure 1A; Zhao et al., 2005).
Quantitative PCR for mature miR-1 in ventricular myocardium
from 8 week old mice showed threefold up-regulation of miR-1
as compared to WT littermates, while other cardiac microRNA
levels were unchanged (Figure 1B).
Because previous work has established that the Myh6
promoter is active during embryogenesis, we tested for up-
regulation of miR-1 expression at several embryonic time points
using quantitative PCR on RNA isolated from WT and miR-
1 TG littermates. These data established the onset of miR-1
FIGURE 1 | Specific Overexpression of MicroRNA-1 in Myh6-MiR-1-TG Mice.
(A) The Myh6 promoter was cloned upstream of pre-miR-1-2 for pronuclear
injection. (B) Quantitative PCR demonstrated that 8 weeks old miR-1 TG mice
had about threefold overexpression of miR-1 as compared to WT littermates.
Expression of other cardiac-enriched microRNAs was unchanged. “∗”
denotes p < 0.05.
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overexpression in miR-1 TG animals between embryonic day (E)
9.5 and E13.5, a critical window within which PF specification
and outgrowth occurs (Figure 2A). Notably, while miR-1 levels in
miR-1 TG embryonic hearts rose rapidly during embryogenesis,
they did not approach WT adult levels until relatively late
in embryogenesis. Embryonic hearts of miR-1 TG and WT
littermates were examined histologically before the onset of miR-
1 expression and no gross defects in cardiac morphogenesis were
observed. MiR-1 TG animals were born at expected frequency
with no evidence of embryonic lethality.
Embryonic Malformation of Ventricular
Conduction System in miR-1 TG Mice
To test whether exposure of the developing heart to elevated
miR-1 levels affected VCS development, we began by examining
the VCS and its precursors before E11.5, when miR-1 levels
begin to rise in the miR-1 TG embryos but before they reach
WT adult levels. In situ hybridization for Bmp10, a molecular
marker for trabecular myocardium, revealed no difference in
ventricular expression pattern between miR-1 TG and WT at
E10.5, suggesting that the specification of VCS precursors was
grossly unaltered in miR-1 TG animals (Figure 2B, left panels).
We then crossed the miR-1 TG animals to the conduction
system reporter mouse line, CCS-LacZ and examined embryos
at different time points. As assessed by CCS-LacZ reporter
activity, WT and TG hearts also had a similar appearance of the
developing VCS at E11.5 (Figure 2B, right panel), confirming
that VCS development is not perturbed prior to the onset of
miR-1 overexpression in the miR-1 TG animals.
Histological comparison of E10.5 with E12.5 hearts, however,
revealed that while trabeculations were well formed in the miR-1
TG hearts, ventricular myocardial growth (including trabecular
growth) was diminished in miR-1 TG hearts after E11.5, when
FIGURE 2 | Hypoplasia of Ventricular Conduction System in miR-1 TG Embryos. (A) Quantitative PCR for mature miR-1 transcript in miR-1 TG hearts versus WT
hearts at several stages of development shows that miR-1 expression is elevated in mid-gestation embryos and rises to adult levels in the perinatal period,
anticipating the normal developmental upregulation of miR-1. The inset shows relative expression of miR-1 versus WT at E11.5. “∗” denotes p < 0.05, “∗∗” denotes
p < 0.01, and “∗∗∗” denotes p < 0.001. (B) Whole-mount in situ hybridization at E10.5 for Bmp10 in WT (top, left) and TG (bottom, left) and VCS development at
E11.5 as assessed by whole-mount bluo-gal staining of a miR-1 TG heart (bottom, right) alongside a WT littermate (top, right) in the CCS-LacZ background. Note
the similar distribution of reporter expression. (C) Light microscopic examination of embryonic hearts sectioned at E10.5 (left) and E12.5 (right) in WT (top) and
miR-TG (bottom). Scale bars = 200 microns. (D) Whole-mount imaging of CCS-Lacz reporter activity at E13.5, after the onset of miR-1 upregulation in miR-1 TG
mice, demonstrates a striking paucity of VCS tissue in the transgenic heart (bottom row) versus a WT littermate (top row). Panels 1–4 on the right show magnified
images of developing RV (1,3) and LV (2,4) PF density in WT (1,2), and TG (3,4) hearts.
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miR-1 levels rise in the miR-1 TG animals (Figure 2C). Similarly,
beginning at E13.5, when miR-1 levels in miR-1 TG embryos
approach WT adult levels, we observed a striking reduction
in VCS tissue in CCS-LacZ transgenic embryos (Figure 2D).
To confirm that the reduction in ventricular growth and VCS
development at E12.5 and E13.5 in miR-1 TG embryos could
be attributed to elevated miR-1 expression, we assessed miR-
1 levels at E11.5 in miR-1 TG and WT animals and observed
a threefold increase in miR-1 expression by this developmental
stage (Figure 2A, inset).
Ventricular Conduction System Structure
and Function in MiR-1 TG Neonates
To test whether the decrease in PF density persisted into the
neonatal period, miR-1 TG;CCS-LacZ hearts were examined
at P5. Consistent with the embryonic findings, we observed
a clear reduction in PFs in the miR-1 TG mice (Figure 3A).
Of note, we observed no reduction in CCS-LacZ reporter
activity in the AV bundle, excluding the possibility that global
reduction in CCS-LacZ promoter activity is responsible for
the PF abnormalities that we observed. We also assessed
the VCS by crossing miR-1 TG animals into the Irx3-LacZ
reporter line, in which reporter activity is restricted to the
VCS. We observed a striking reduction in PFs in the miR-1
TG animals in this line as well (Supplementary Video S1).
Quantification of PF density by measurement of Irx3-
LacZ reporter staining intensity, as shown in Figures 3B,C,
demonstrated a robust and statistically significant reduction
in 5 miR-1 TG hearts as compared to 3 WT littermate
hearts. Taken together, these data demonstrate that premature
up-regulation of miR-1 expression during embryogenesis
causes PF hypoplasia.
We also assessed expression of critical functional genes
in postnatal (P10) VCS cells, including Connexin-40 and
Nav1.5, which contribute to the rapid conduction phenotype
of these cells. While we did not observe any difference in
Nav1.5 expression throughout the subendocardial myocardium,
quantitative immunohistochemistry of VCS Connexin-40
expression revealed a 45% reduction in the intensity of connexin-
40 plaques in miR-1 TG VCS cells as compared to WT littermates,
demonstrating an effect of miR-1 on gene expression in VCS
cells in addition to an effect on cellularity (Supplementary
Figures S1A,B). Consistent with previous work on miR-1, we
also observed moderate reduction in Connexin-43 staining
in the ventricular working myocardium of miR-1 TG hearts
(Supplementary Figure S1C).
To test whether the VCS hypoplasia and reduced Cx-40 and
Cx-43 expression were associated with VCS dysfunction, we
performed electrocardiograms in neonatal mice derived from 3
separate litters (n = 5 for miR-1 TG and n = 8 for WT). We
measured the RR interval (reflecting heart rate), the PR interval
(reflecting conduction through the AV node) and the QRS
interval (reflecting conduction along the VCS). We found that
while RR and PR intervals were not changed between miR-1 TG
neonates and their littermates, the QRS interval was significantly
increased in the miR-1 TG mice (p < 0.05), demonstrating
isolated dysfunction of the VCS in hearts with PF hypoplasia and
dysregulation of gene expression (Figures 3D,E).
Conduction System Hypoplasia and
Dysfunction Persists in Adult MiR-1 TG
Hearts
To test whether conduction system hypoplasia persisted in adult
hearts, we crossed miR-1 TG mice with the CCS-LacZ line, in
which the entire VCS is labeled with LacZ, and performed whole-
mount bluo-gal staining in adult mice at 8 weeks. Similar to
findings in neonates and embryos, we observed reduction in the
caliber and density of PFs in miR-1 TG mice as compared to WT
littermates (Figure 4A).
If the ratio of PF to working myocardium is reduced in
miR-1 TG animals, we reasoned that there should be relatively
lower expression of PF enriched genes in the ventricles of TG
hearts. To test this directly, we performed quantitative PCR to
assess gene expression in ventricular tissue dissected from miR-
1 TG and WT hearts. Whereas expression of pan-ventricular
cardiac transcription factors Nkx2.5 and Tbx5 were not changed
between the two genotypes, and Gata4 expression was only
mildly reduced, expression levels of genes highly enriched in PF,
including Gja5, Hcn4, and Irx3, were reduced by 38, 73, and 29
percent, respectively (Figure 4B).
Finally, to test for functional abnormalities of the VCS
in adult miR-1 TG mice, we performed electrocardiograms
in anesthetized adult miR-1 TG mice. Compared to their
WT littermates, miR-1 TG mice exhibited slower heart rate,
prolonged PR interval (reflecting delayed conduction through
the AV node) and prolonged QRS duration, reflecting delayed
conduction through the VCS (Figures 4C,D).
While prolonged QRS duration is likely a consequence of
the VCS abnormalities we defined (hypoplasia and reduced
connexin-40 expression), the PR interval increase is a distinct
electrophysiological abnormality that suggests abnormal function
of the AV node and/or AV bundle. We used acetylcholinesterase
staining, which marks central conduction tissue, and observed
no gross difference between miR-1 TG animals and WT animals
in the size of the AV node or AV bundle. We further assessed
these structures with immunohistochemistry for Hcn4 (AV node)
and connexin-40 (AV bundle), and observed no differences in
morphology of these structures between WT and miR-1 TG
hearts although staining intensity for these proteins was reduced
in miR-1 TG hearts (Supplementary Figures S1D,E). Thus,
slowed conduction through the structurally intact AV node is
likely due to functional abnormalities caused by chronic exposure
to elevated miR-1 levels, as has been described previously, and not
to hypoplasia (Zhang et al., 2013).
MiR-1 Inhibits Proliferation of VCS
Precursors
VCS cells are specified and differentiate from bipotent
proliferative trabecular myocardium. Therefore, VCS hypoplasia
could have resulted from impaired trabeculation, impaired
specification of the VCS, or from reduced proliferation of
specified VCS and/or trabecular precursor cells. Because
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FIGURE 3 | Abnormal Conduction System Structure and Function in MiR-1 TG Neonatal Mice. (A) Whole mount imaging of CCS-LacZ reporter activity in P5 hearts
shows a reduction in PF density in the TG heart (bottom, left) versus the WT littermate (top, left). The magnified panels 1–4 (right) demonstrate atrioventricular bundle
tissue (AVB; 1,3) and Purkinje Fiber (PF) density (PF; 2,4) in the WT (1,2) and miR-1 TG hearts (3,4). (B) Whole-mount imaging of reporter activity in WT (top) and TG
(bottom) P5 hearts in the Irx3-LacZ background. Left panels show imaging of the left bundle branch and left-sided Purkinje fibers. Right panels show magnified
images of right ventricular PFs. (C) Density of PFs in WT (n = 3) and miR-1 TG (n = 5) hearts were quantified from images of reporter activity in Irx3-LacZ hearts.
Representative images for quantification are shown at top. The density of PFs was significantly reduced in miR-1 TG hearts, as shown in the bottom graph (“∗∗”
denotes p < 0.01). (D) Averaged lead aVF ECG tracings recorded from a neonatal WT mouse (top) and a miR-TG littermate show prolongation of the QRS duration
in the miR-1 TG, reflecting slowed conduction through the VCS. (E) RR, PR, and QRS intervals quantified from WT and miR-1 TG mice (mice obtained from 3
distinct litters, n = 8 for WT and n = 5 for TG, “∗” denotes p < 0.05).
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FIGURE 4 | Abnormal Conduction System Structure in Adult MiR-1 TG Mice. (A) Whole mount imaging after fixation and bluo-gal staining of the ventricular
conduction system in WT (top) and miR-1 TG (bottom) hearts in the CCS-LacZ background. PF density is reduced in the miR-1 TG adult hearts. (B) Quantitative
PCR for genes enriched in PFs demonstrates decreased expression of conduction system genes and either unchanged or only modest changes in core cardiac
transcription factors. “∗” denotes p < 0.05, “∗∗” denotes p < 0.01, and “∗∗∗” denotes p < 0.001; NS, non-significant. (C) Averaged ECG tracings derived from limb
lead aVF from 8 weeks old WT (top) and miR-1 TG mice (bottom) demonstrated prolonged PR and QRS in the miR1-TG. (D) Comparison of electrocardiographic
intervals in adult WT mice (n = 7) and miR-1 TG littermates (n = 8) demonstrate prolonged RR, PR, and QRS intervals in the miR-1 TG mice, reflecting widespread
conduction system dysfunction.
miR-1 negatively regulates proliferation in other contexts,
we hypothesized that increasing miR-1 in embryonic hearts
might have led to reduced proliferation within the trabecular
myocardial compartment, which, in turn, would have reduced
the available pool from which VCS cells are ultimately
recruited. To test this hypothesis, we used phosphohistone
H3 immunohistochemistry on E12.5 embryonic heart sections
from miR-1 TG and WT littermates (3 animals per genotype
from 2 different litters with 2 sections per embryo, Figure 5A).
We manually segmented the trabecular myocardium and in this
compartment we found a significantly reduced mitotic index
in the TG animals as compared to WT littermates, confirming
our hypothesis of hypoproliferation of VCS precursors. We
also segmented and assessed mitotic index in the compact
myocardium and observed a similar reduction in the miR-1 TG
animals (4.2% in WT versus 2.9% in miR-1 TG, p< 0.05).
Finally, to test directly whether proliferation is reduced
in the VCS compartment, we stained sections from E12.5
Irx3-LacZ;MiR-1TG and Irx3-LacZ littermate embryos for
beta-galactosidase expression and phosphohistone H3 (3
animals per genotype from 2 different litters with 2 sections
per embryo). Mitotic index specifically within the beta-
galactosidase + (Irx3 + VCS) cells showed a significant
reduction in miR-1 TG as compared to WT cells, confirming
that early miR-1 up-regulation results in decreased proliferation
of VCS precursors (2.5% in WT versus 1.6% in miR-1 TG,
p< 0.001, Figure 5B).
MiR-1 Regulates Cdk6 Expression
Cdk6, an established miR-1 target in rat models, acts upstream
of the pocket proteins, regulators of trabecular proliferation and
conduction system cellularity (Liao et al., 2016). We therefore
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FIGURE 5 | MiR-1 Negatively Regulates VCS Proliferation and Cdk-6 Protein
Expression. (A) Phosphohistone H3 staining in WT and miR-1 TG hearts at
E12.5 shows a reduction in PH3+ cells in transgenic animals as compared to
WT. The graph shows the percentage of trabecular nuclei that are PH3+ in
each genotype. “∗∗∗” denotes p < 0.001. (B) Co-staining of phosphohistone
H3 and beta-galactosidase in Irx3-LacZ and Irx3-LacZ; MiR-1 TG E12.5
hearts demonstrates reduced mitotic index specifically in the developing VCS.
The graph shows the percentage of beta-galactosidease nuclei that are also
phosphohistone H3 positive “∗∗∗” denotes p < 0.001. (C) mRNA level of
Cdk6 is unchanged in postnatal hearts from miR-1 TG versus WT littermates,
while protein level is significantly decreased, consistent with translational
regulation. Knockdown of miR-1 in HL-1 cells results in upregulation of Cdk6
at the protein level. ∗ denotes p < 0.05.
tested whether Cdk6 might also be a target of miR-1 in the mouse
heart, and thereby explain the proliferation defect observed in
trabecular myocardium. Cdk6 mRNA levels were not different
between TG and WT littermates (Figure 5C). Cdk6 protein
levels, however, were markedly reduced in miR-1 transgenic
hearts, consistent with posttranscriptional down-regulation by
miR-1. Furthermore, knockdown of miR-1 in cultured HL-1 cells
increased Cdk6 protein levels (Figure 5C). Taken together, these
results suggest that a miR-1/Cdk6 pathway may also be relevant
to miR-1’s function in vivo during the postnatal period when
cardiomyocyte proliferation slows.
Abnormal Cardiac Growth in Adult MiR-1
TG Hearts
Consistent with previous work, additional studies performed on
adult miR-1 TG adult mice revealed age-dependent ventricular
enlargement, arrhythmias including AV block, and premature
death as compared to WT controls (Supplementary Figure
S2; Ai et al., 2012; Zhang et al., 2013). Notably, despite the
conduction abnormalities, ventricular function as assessed by
echocardiography was preserved at 8 weeks, although we did
observe ventricular chamber enlargement. This finding, along
with preserved wall thickness and increased cardiac mass,
suggested the presence of cardiac hypertrophy (Supplementary
Table S2). To test directly for the presence of cardiac cellular
hypertrophy, we examined WT and miR-1 TG hearts at
P10 by staining for wheat germ agglutinin, which labels the
myocardial interstitium and allows direct visualization of cell
boundaries. Quantification of myocyte cross sectional area in
miR-1 TG animals revealed a significant enlargement in cell
size as compared to WT littermates (Supplementary Figures
S3A–C). Although a previous study defined abnormalities in
sarcomere assembly that contribute to hypertrophy, reduced cell
number could also theoretically contribute to abnormal growth
by triggering hypertrophy as a compensatory mechanism. To
test directly whether miR-1 TG hearts had reduced cell number,
we counted the number of cell layers between endocardium and
epicardium at several sites along the ventricular walls in miR-1
TG P10 hearts and WT littermates. As expected, miR-TG hearts
exhibited a lower cell count as compared to WT littermates,
despite an overall increase in wall thickness and cardiac mass
(Supplementary Figure 3D).
DISCUSSION
In this report, we have used a transgenic mouse line with miR-
1 overexpression under the control of the Myh6 promoter to
define the impact of increased embryonic miR-1 dosage on
structure and function of the VCS. Our main findings are
(1) the Purkinje system is hypoplastic and exhibits abnormal
function in neonatal and adult miR-1 TG mice, and (2) premature
upregulation and overexpression of miR-1 in the mid-embryonic
and perinatal period inhibits proliferation of PF precursors,
possibly through direct regulation of the cyclin-dependent
kinase Cdk6. Taken together, our findings corroborate previous
reports of arrhythmias caused by increased levels miR-1, and
demonstrate that the timing of miR-1 expression is important for
development of the VCS.
Effect of Premature and Increased MiR-1
Expression on Conduction System
Proliferation
MiR-1 is the most abundant microRNA in the adult mouse
heart, accounting for 35–40% of the total amount of miRNA
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(Rao et al., 2009) MiR-1 directly targets connexin-43 (Yang et al.,
2007), KcnJ2 (Yang et al., 2007), Kcne1 (Jia et al., 2013), Ncx1
(Kumarswamy et al., 2012), PP2A/RyR2 (Terentyev et al., 2009),
and Hcn4 (D’Souza et al., 2014) in the adult heart (reviewed in
Liao et al., 2016), contributing to the arrhythmias that we and
others observed in miR-1 TG adult hearts.
However, in the developmental context, miR-1 is an
established negative regulator of cellular proliferation.
Accordingly, during heart development, miR-1 levels are
relatively low, but rise steeply during the maturation period
beginning in late development, supporting the notion that the
timing of miR-1 up-regulation is an important determinant
of the reduction in proliferation seen during perinatal cardiac
maturation (de Boer et al., 2012). Further supporting such a role,
loss of miR-1 increases the fraction of cardiomyocytes actively
proliferating and prolongs the proliferative period in early
perinatal development (Zhao et al., 2007), while overexpression
of miR-1 early in embryogenesis results in developmental arrest
due to decreased proliferation (Zhao et al., 2005).
The present work is the first to focus on VCS morphogenesis in
the context of developmental dysregulation of miR-1 expression.
Mammalian PF cells differentiate from a slowly proliferating
bipotent pool of ventricular trabecular cardiomyocytes (Gourdie
et al., 1995; Miquerol et al., 2010), and subsequently PF cells
(located at the tips of trabeculations) proliferate more slowly than
compact myocardium (de Boer et al., 2012), resulting in a precise
ratio of PF to working myocardium. The gradient in proliferative
rate within the developing myocardium is maintained, in part, by
the three pocket proteins Rb, p107, and p130, which collectively
regulate cell cycling in PF cells and trabecular cardiomyocytes
through their interactions with E2F transcription factors. In their
complete absence, the PFs and trabecular myocardium exhibit
excessive proliferation, leading to compromised cardiac function
(Park et al., 2013).
Cdk4 and Cdk6 act upstream of the pocket proteins in
regulating embryonic cardiomyocyte cell cycling (Ahuja et al.,
2007). While Cdk6 is an established cell cycle regulator in
embryonic myocardium, a role for Cdk6 specifically in PF
development has not been defined. A previous report identified
and validated a conserved miR-1 target site in rat Cdk6 leading
us to examine this cell cycle regulator in our miR-1 TG model
(Yuan et al., 2016). We confirmed that Cdk6 levels are reduced in
miR-1 TG hearts, and that mouse Cdk6 is also a miR-1 target.
Taken together, these data provide support for our hypothesis
that Cdk6 may be an important mediator of the negative effect
of miR-1 on embryonic cardiomyocyte proliferation (Figure 6),
although we cannot exclude the possibility of other relevant miR-
1 target genes that might contribute to the observed phenotype,
nor can we exclude the possibility of non-cell autonomous effects
of miR-1 on proliferation of VCS precursor cells.
Relationship of PF Hypoplasia to VCS
Function
In addition to observing a negative effect of miR-1 on embryonic
trabecular and VCS proliferation, we also note that miR-1
negatively regulates proliferation throughout the myocardium,
FIGURE 6 | Working Model for Role of MiR-1 in VCS Proliferation. MiR-1
negatively regulates Cdk6, which binds to Cyclin D to inhibit the action of the
pocket proteins, negative regulators of VCS cellularity. The net effect of Cdk6
reduction is increased activity of pocket proteins and thus reduced
proliferation in the VCS.
including the compact zone, leading to a reduction in cell count in
the mature heart. Thus, on the surface it may seem puzzling that
a global reduction in myocardial proliferation would manifest
predominantly via cardiac conduction system dysfunction. One
explanation is that conduction tissue may be more sensitive
to reduction in total cell number than working myocardium.
Careful lineage tracing has demonstrated that by the end of
cardiac development and maturation, VCS cells comprise about
1% of the total number of cardiomyocytes. Thus although
working cardiomyocytes also have reduced numbers in miR-1
TG animals, they retain the capacity to hypertrophy and can
thereby compensate for a decrease in force generating units by
increasing the force generated per unit. VCS cells, in contrast,
may have limited capacity to change their conduction properties
to compensate for even a modest reduction of VCS cell number.
This difference between VCS cells and working myocytes could
explain why contractile function was relatively preserved in miR-
1 TG hearts despite severe disruptions in VCS function. In
addition, our finding of reduced Cx-40 expression specifically
in VCS cells and globally reduced connexin-43 expression
with overall hypertrophy would likely further exacerbate
conduction failure by worsening source-sink matching at the
PF-myocardium interface. Testing this hypothesis directly with
optical mapping of the PF-myocardium junction is beyond the
scope of the present work. However, in future work the miR-
1 TG adult mouse could serve as an instructive model of how
impulse propagation can be compromised in the setting of VCS
degeneration and cardiomyopathy.
Abnormal Cardiac Growth and Early
Death in MiR-1 TG Mice
Previous studies that have examined miR-1 overexpression in
the adult heart have also noted the presence of progressive AV
block, ventricular hypertrophy, and ultimately age-dependent
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ventricular enlargement with contractile dysfunction. These
striking phenotypes have been attributed to upstream effects of
miR-1 on a number of specific target genes, including some
that regulate impulse propagation and arrhythmogenesis (Zhang
et al., 2013), and others that regulate sarcomere assembly (Ai
et al., 2012). Here, we demonstrate that in addition to these effects
on gene expression in adult hearts, early developmental up-
regulation and overexpression of miR-1 has important effects on
cardiac morphogenesis and cellularity in the VCS and elsewhere.
Although it is not possible to define with certainty the relative
contribution of each of these factors to the complex adult
phenotype, based on our findings of early-onset prolonged QRS
duration in neonatal mice in the absence of any other cardiac
phenotypes at that time, we propose that VCS hypoplasia and
dysfunction make a significant contribution to abnormal impulse
propagation in the postnatal ventricles in miR-1 TG mice, while
reduced ventricular cell number could result in hypertrophy as
part of an adaptive response.
Relevance to Human Heart Disease
Although miR-1 dysregulation has been implicated in the
pathogenesis of human persistent atrial fibrillation (Girmatsion
et al., 2009), a role for miR-1 in regulating AV conduction and
VCS function in humans has not yet been defined. However, it
is notable that mutations in Nkx2.5, an upstream repressor of
miR-1, can cause progressive cardiac conduction disease (PCCD),
raising the possibility that this pathway may be relevant to the
pathophysiology of at least some forms of PCCD. Further work
will be required to test whether miR-1 might play a role in
congenital or acquired conduction system disease in humans,
and to test whether alteration of miR-1 dosage during defined
temporal windows might have a therapeutic role in conduction
system disease. In theory, transient reduction of miR-1 dosage
in the VCS might offer a means to rescue VCS proliferation in
diseases caused by VCS malformation.
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FIGURE S1 | Immunohistochemistry of Conduction Tissue in MiR-1 TG Mice. (A)
Connexin-40 staining of WT (top panels) and TG (bottom panels) demonstrates
connexin-40+ subendocardial Purkinje cells. The boxed regions are magnified in
the right panels to show connexin-40 plaques in individual VCS cells. (B)
Quantification of fluorescence intensity of Cx40 plaques relative to background
shows a significant reduction in Cx40 protein in TG as compared to WT cells
(n = 40 WT, n = 32 miR-1 TG, “∗∗∗” denotes p < 0.001). (C)
Immunohistochemistry for NaV1.5 (left panels) was similar between WT and miR-1
TG, while Cx43 protein expression (right panels) was reduced in miR-1 TG hearts.
(D) Immunohistochemical staining of AV node with Hcn4 (left) and AV bundle and
right bundle branch with Cx40 (right) in WT (top) and miR-1 TG (bottom) adult
hearts. (E) Acetylcholinesterase staining of WT (top) and miR-1 TG (bottom) AV
node (left) and AV bundle (right). Scale bars = 50 microns.
FIGURE S2 | MiR-1 TG Mice Exhibit Cardiac Enlargement, AV block, and Early
Death. (A) Gross examination of miR-1 TG hearts versus WT littermate hearts at 4
time points revealed normal cardiac structure with modest age-dependent
enlargement in miR-1 TG hearts. (B) Quantification of heart weight to body weight
ratio (HW/BW) demonstrated that miR-1 TG animals are similar to WT littermates
at birth, but subsequently develop an increase in HW/BW ratio. Abbreviations: P0,
postnatal day 0; W, weeks postnatal, NS, non-significant. “∗∗∗” denotes P-value
less than 0.001. (C) Examples of spontaneous AV block occurring in three
different awake miR-1 TG animals with implanted ECG transmitters.
A simultaneous tracing obtained from a WT littermate is shown for comparison
(top tracing). P waves that are not followed by QRS complexes, reflecting AV
block, are denoted with arrows. AV block was observed in all miR-1 TG mice but
in none of the WT littermates. (D) Kaplan-Meier curves for miR-1 TG and WT
littermates demonstrate early lethality for miR-1 TG animals.
FIGURE S3 | Myocardial Hypertrophy and Cellularity in MiR-1 TG Mice. (A)
Ventricular wall of WT (left) and miR-1 TG (right) hearts at P10 stained for wheat
germ agglutinin demonstrates decreased cell number in miR-1 TG hearts. Scale
bars = 100 microns. (B) Closer view of wheat germ agglutinin staining shows
increased cross sectional area of myocardial cells in TG (right) versus WT
littermates (left). (C) Quantification of cellular cross-sectional area in miR-1 TG
versus WT P10 mouse hearts. (D) Quantification of number of cell layers between
epicardium and endocardium, a surrogate measure of cell number, in left ventricle
and right ventricle of WT and miR-1 TG P10 hearts. “∗∗∗” denotes p < 0.001.
TABLE S1 | Echocardiographic Parameters in Awake MiR-1 TG
and WT Adult Mice.
TABLE S2 | Quantitative PCR Probes.
VIDEO S1 | Optical projection tomography was used to visualize the VCS in
miR-1 TG; Irx3-LacZ neonatal hearts and Irx3-LacZ littermates after fixing, staining
with bluo-gal, clearing, and scanning. Three-dimensional reconstructions of virtual
sections demonstrate markedly reduced Purkinje Fibers in the miR-1 TG hearts,
similar to findings from crosses to CCS-LacZ.
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